Literature DB >> 26789999

Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.

Kenichiro Takahashi1, Atsushi Nishida, Takehide Fujimoto, Makoto Fujii, Makoto Shioya, Hirotsugu Imaeda, Osamu Inatomi, Shigeki Bamba, Mitsushige Sugimoto, Akira Andoh.   

Abstract

BACKGROUND: The global alteration of the gut microbial community (dysbiosis) plays an important role in the pathogenesis of inflammatory bowel diseases (IBDs). However, bacterial species that characterize dysbiosis in IBD remain unclear. In this study, we assessed the alteration of the fecal microbiota profile in patients with Crohn's disease (CD) using 16S rRNA sequencing.
SUMMARY: Fecal samples from 10 inactive CD patients and 10 healthy individuals were subjected to 16S rRNA sequencing. The V3-V4 hypervariable regions of 16S rRNA were sequenced by the Illumina MiSeq™II system. The average of 62,201 reads per CD sample was significantly lower than the average of 73,716 reads per control sample. The genera Bacteroides, Eubacterium, Faecalibacterium and Ruminococcus significantly decreased in CD patients as compared to healthy controls. In contrast, the genera Actinomyces and Bifidobacterium significantly increased in CD patients. At the species level, butyrate-producing bacterial species, such as Blautia faecis, Roseburia inulinivorans, Ruminococcus torques, Clostridium lavalense, Bacteroides uniformis and Faecalibacterium prausnitzii were significantly reduced in CD patients as compared to healthy individuals (p < 0.05). These results of 16S rRNA sequencing were confirmed in additional CD patients (n = 68) and in healthy controls (n = 46) using quantitative PCR. The abundance of Roseburia inulinivorans and Ruminococcus torques was significantly lower in C-reactive protein (CRP)-positive CD patients as compared to CRP-negative CD patients (p < 0.05). KEY MESSAGE: The dysbiosis of CD patients is characterized by reduced abundance of multiple butyrate-producing bacteria species.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26789999     DOI: 10.1159/000441768

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  168 in total

1.  Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice.

Authors:  Yin Zhu; Cong He; Xueyang Li; Yan Cai; Jinxiang Hu; Yuanhang Liao; Jianhua Zhao; Liang Xia; Wenhua He; Linmeng Liu; Chun Luo; Xu Shu; Qiang Cai; Youxiang Chen; Nonghua Lu
Journal:  J Gastroenterol       Date:  2018-12-05       Impact factor: 7.527

2.  Sparse support vector machines with L0 approximation for ultra-high dimensional omics data.

Authors:  Zhenqiu Liu; David Elashoff; Steven Piantadosi
Journal:  Artif Intell Med       Date:  2019-04-30       Impact factor: 5.326

Review 3.  Gut microbiota-immune-brain interactions in chemotherapy-associated behavioral comorbidities.

Authors:  Kelley R Jordan; Brett R Loman; Michael T Bailey; Leah M Pyter
Journal:  Cancer       Date:  2018-07-05       Impact factor: 6.860

4.  Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis.

Authors:  Atsushi Nishida; Hirotsugu Imaeda; Masashi Ohno; Osamu Inatomi; Shigeki Bamba; Mitsushige Sugimoto; Akira Andoh
Journal:  J Gastroenterol       Date:  2016-10-11       Impact factor: 7.527

5.  The nursing home elder microbiome stability and associations with age, frailty, nutrition and physical location.

Authors:  John P Haran; Vanni Bucci; Protiva Dutta; Doyle Ward; Beth McCormick
Journal:  J Med Microbiol       Date:  2017-11-14       Impact factor: 2.472

Review 6.  Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease.

Authors:  M N Quraishi; W Shaheen; Y H Oo; T H Iqbal
Journal:  Clin Exp Immunol       Date:  2019-11-27       Impact factor: 4.330

Review 7.  Signals from the gut microbiota to distant organs in physiology and disease.

Authors:  Bjoern O Schroeder; Fredrik Bäckhed
Journal:  Nat Med       Date:  2016-10-06       Impact factor: 53.440

8.  Smarcad1 mediates microbiota-induced inflammation in mouse and coordinates gene expression in the intestinal epithelium.

Authors:  Juri Kazakevych; Jérémy Denizot; Anke Liebert; Mariana Portovedo; Mia Mosavie; Payal Jain; Claudia Stellato; Claire Fraser; Renan Oliveira Corrêa; Marina Célestine; Raphaël Mattiuz; Hanneke Okkenhaug; J Ross Miller; Marco Aurélio Ramirez Vinolo; Marc Veldhoen; Patrick Varga-Weisz
Journal:  Genome Biol       Date:  2020-03-11       Impact factor: 13.583

9.  Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment.

Authors:  Nai-Lun Yeh; Che-Yuan Hsu; Tsen-Fang Tsai; Hsien-Yi Chiu
Journal:  Clin Drug Investig       Date:  2019-12       Impact factor: 2.859

Review 10.  Deciphering interactions between the gut microbiota and the immune system via microbial cultivation and minimal microbiomes.

Authors:  Thomas Clavel; João Carlos Gomes-Neto; Ilias Lagkouvardos; Amanda E Ramer-Tait
Journal:  Immunol Rev       Date:  2017-09       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.